Pancreatic cancer pill shown to nearly double overall survival time, drug company says

A pancreatic cancer drug developed by a pharmaceutical company demonstrated significant improvements in patient survival, nearly doubling overall survival time. The company claims the treatment offers clinically meaningful benefits for patients with advanced pancreatic cancer.